“Through working with the CDP, each of us will provide a piece of a giant jigsaw puzzle. The pieces don’t fit at first, and then a few do, and then more are added, until one day all the pieces make a whole, and that is the day diabetics around the world are dreaming of. The day will come; of this I am certain. ”
Yong Wang, M.D., University of Illinois at Chicago, Chicago, IL.
Human pancreatic cells, or islets, will be our main tool for achieving a functional cure. We have a well established procedure, known as the Islet Isolation Procedure, for obtaining these cells from donor pancreases. This approach differs significantly from current standard of injecting insulin for treating persons with type-1 diabetes. Insulin injections cannot replicate the control of blood glucose levels that is exhibited by actual living pancreatic islets.
There are clear and exciting benefits that result from this control. First, it eliminates the need for insulin injections (please see patient testimonials). It follows that this control eliminates the incidence of acute low blood glucose that can result in dangerous hypoglycemic events. This is all possible, because the cells have the inner workings to appropriately release the insulin hormone, to decrease blood glucose, or release the glucagon hormone, to increase blood glucose when necessary.
In effect, islet cell therapy has the potential to restore the natural signal-response mechanism for controlling blood glucose. This control can potentially prevent many of known, devastating effects of long-term Type-1 Diabetes.
Your contribution will help doctors and scientists all over the world to bring an end to diabetes of all types. Together we can brighten the lives of people across the globe.
